Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “
Company” or “
Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“
Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products.
Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he specialized in Internal Medicine, and received his sub-specialty training in Infectious Diseases at University of Toronto. Following completion of his medical and specialty training, Dr. Ferro returned to Bogotá and established a private practice in both Internal Medicine and Infectious Diseases, while at the same time held academic positions at different teaching hospitals.
Published: May 05, 2021
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “
Company” or “
Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“
Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products.
Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he specialized in Internal Medicine, and received his sub-specialty training in Infectious Diseases at University of Toronto. Following completion of his medical and specialty training, Dr. Ferro returned to Bogotá and established a private practice in both Internal Medicine and Infectious Diseases, while at the same time held academic positions at different teaching hospitals.
Core One Labs Inc.: Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the
Company or
Core One ) announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth Opportunity Corporation) (PBIC) (
PBIC ) to rescind the share exchange transaction previously completed between the parties (the
Share Exchange ).
Effective March 16, 2020, the Company subscribed for and acquired 3,149,606 common shares of PBIC, and in consideration issued 5,333,333 common shares to PBIC (or 2,666,667 common shares after giving effect to the share consolidation completed by the Company on July 8, 2020). The Company and PBIC have agreed to rescind the Share Exchange and return to treasury and cancel all securities of the Company and PBIC issued in connection with the transaction.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
April 15, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the Company or Core One ) announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth .
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the Company or Core One ) announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth .
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp digitalfacility.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitalfacility.com Daily Mail and Mail on Sunday newspapers.